mtr105
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2008 (NCT00482287)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Inducible nitric oxide synthaseINHIBITOR
Inducible nitric oxide synthase inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mtr105
- mtr105
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00482287 | Phase 2 | Jan 1, 2008 | Meditor Pharmaceuticals Ltd., University of Pittsburgh |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Meditor Pharmaceuticals Ltd. | For profit | 1 | 1 | 1 | 2008 |
| University of Pittsburgh | Academic/Hospital | 1 | 0 | 1 | 2008 |
2 organizations
Page 1 / 1